Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Miksch, A; Hermann, K; Rölz, A; Joos, S; Szecsenyi, J; Ose, D; Rosemann, T (2009). Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany - a cross-sectional survey. Health and Quality of Life Outcomes, 7:19.

Bölter, R; Natanzon, I; Miksch, A; Joos, S; Rosemann, T; Szecsenyi, J; Götz, K (2009). Kommunale Ressourcen als ein Element des „Chronic care Modells“: eine qualitative Studie mit Hausärzten. Prävention und Gesundheitsförderung, 4(1):35-40.

Pfister, S; Remke, M; Benner, A; Mendrzyk, F; Toedt, G; Felsberg, J; Wittmann, A; Devens, F; Gerber, N U; Joos, S; Kulozik, A; Reifenberger, G; Rutkowski, S; Wiestler, O D; Radlwimmer, B; Scheurlen, W; Lichter, P; Korshunov, A (2009). Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. Journal of Clinical Oncology, 27(10):1627-1636.

Szecsenyi, J; Rosemann, T; Joos, S; Peters-Klimm, F; Miksch, A (2008). German diabetes disease management programs are appropriate for restructuring care according to the chronic care model: an evaluation with the patient assessment of chronic illness care instrument. Diabetes Care, 31(6):1150-1154.

Joos, S; Musselmann, B; Miksch, A; Rosemann, T; Szecsenyi, J (2008). The role of complementary and alternative medicine (CAM) in Germany - a focus group study of GPs. BMC Health Services Research, 8:127.

Rosemann, T; Joos, S; Szecsenyi, J (2008). Wie leitliniengerecht ist die Behandlung degenerativer Gelenkerkrankungen in der hausärztlichen Praxis? Ein Vergleich internationaler Leitlinien mit selbst berichtetem Vorgehen. Der Orthopäde, 37(1):69-74.

Bentz, M; Barth, T F; Brüderlein, S; Bock, D; Schwerer, M J; Baudis, M; Joos, S; Viardot, A; Feller, A C; Müller-Hermelink, H K; Lichter, P; Döhner, H; Möller, P (2001). Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes, Chromosomes & Cancer, 30(4):393-401.

Werner, C A; Döhner, H; Joos, S; Trümper, L H; Baudis, M; Barth, T F; Ott, G; Möller, P; Lichter, P; Bentz, M (1997). High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. American Journal of Pathology, 151(2):335-342.

Bentz, M; Döhner, H; Werner, C A; Huck, K; Baudis, M; Joos, S; Schlegelberger, B; Trümper, L H; Feller, A C; Pfreundschuh, M (1995). Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization. Stem Cells, 13(3):83-87.

This list was generated on Mon May 20 15:33:25 2019 CEST.